| Mechanical regulation of glycolysis via cytoskeleton architecture JS Park, CJ Burckhardt, R Lazcano, LM Solis, T Isogai, L Li, CS Chen, ... Nature 578 (7796), 621-626, 2020 | 390 | 2020 |
| Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Y Chu, E Dai, Y Li, G Han, G Pei, DR Ingram, K Thakkar, JJ Qin, M Dang, ... Nature medicine 29 (6), 1550-1562, 2023 | 70 | 2023 |
| Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer L Federico, DJ McGrail, SE Bentebibel, C Haymaker, A Ravelli, MA Forget, ... Annals of Oncology 33 (1), 42-56, 2022 | 65 | 2022 |
| Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy CP Vellano, MG White, MC Andrews, M Chelvanambi, RG Witt, ... Nature 606 (7915), 797-803, 2022 | 61 | 2022 |
| Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells Y Goyal, GT Busch, M Pillai, J Li, RH Boe, EI Grody, M Chelvanambi, ... Nature 620 (7974), 651-659, 2023 | 48 | 2023 |
| Challenges and opportunities for immunoprofiling using a spatial high-plex technology: the NanoString GeoMx® digital spatial profiler S Hernandez, R Lazcano, A Serrano, S Powell, L Kostousov, J Mehta, ... Frontiers in oncology 12, 890410, 2022 | 42 | 2022 |
| The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma D Hao, G Han, A Sinjab, LI Gomez-Bolanos, R Lazcano, A Serrano, ... Cancer discovery 12 (11), 2626-2645, 2022 | 41 | 2022 |
| Multiplex immunofluorescence tyramide signal amplification for immune cell profiling of paraffin-embedded tumor tissues S Hernandez, F Rojas, C Laberiano, R Lazcano, I Wistuba, ER Parra Frontiers in molecular biosciences 8, 667067, 2021 | 35 | 2021 |
| Pilot clinical trial of perioperative durvalumab and tremelimumab in the treatment of resectable colorectal cancer liver metastases P Kanikarla Marie, C Haymaker, ER Parra, YU Kim, R Lazcano, S Gite, ... Clinical Cancer Research 27 (11), 3039-3049, 2021 | 32 | 2021 |
| Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy CJ Terranova, M Tang, M Maitituoheti, AT Raman, AK Ghosh, J Schulz, ... Cell reports 36 (3), 2021 | 20 | 2021 |
| Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state V Kochat, AT Raman, SM Landers, M Tang, J Schulz, C Terranova, ... Acta neuropathologica 142, 565-590, 2021 | 18 | 2021 |
| Multiplex immunofluorescence and the digital image analysis workflow for evaluation of the tumor immune environment in translational research F Rojas, S Hernandez, R Lazcano, C Laberiano-Fernandez, ER Parra Frontiers in Oncology 12, 889886, 2022 | 15 | 2022 |
| Comprehensive surfaceome profiling to identify and validate novel cell-surface targets in osteosarcoma Y Wang, X Tian, W Zhang, Z Zhang, R Lazcano, P Hingorani, ME Roth, ... Molecular cancer therapeutics 21 (6), 903-913, 2022 | 14 | 2022 |
| The FUS:: DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma HJ Zullow, A Sankar, DR Ingram, DDS Guerra, AR D’Avino, CK Collings, ... Molecular cell 82 (9), 1737-1750. e8, 2022 | 14 | 2022 |
| The immune landscape of undifferentiated pleomorphic sarcoma R Lazcano, CM Barreto, R Salazar, F Carapeto, RS Traweek, CH Leung, ... Frontiers in Oncology 12, 1008484, 2022 | 12 | 2022 |
| Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin WW Liang, RJH Lu, RG Jayasinghe, SM Foltz, E Porta-Pardo, Y Geffen, ... Cancer cell 41 (9), 1567-1585. e7, 2023 | 8 | 2023 |
| Pathology quality control for multiplex immunofluorescence and image analysis assessment in longitudinal studies R Lazcano, F Rojas, C Laberiano, S Hernandez, ER Parra Frontiers in Molecular Biosciences 8, 661222, 2021 | 8 | 2021 |
| Proteogenomic insights suggest druggable pathways in endometrial carcinoma Y Dou, L Katsnelson, MA Gritsenko, Y Hu, B Reva, R Hong, YT Wang, ... Cancer cell 41 (9), 1586-1605. e15, 2023 | 7 | 2023 |
| Tumor immune microenvironment alterations in penile squamous cell carcinoma using multiplex immunofluorescence and image analysis approaches. J Chahoud, F Netto, R Lazcano Segura, ER Parra Cuentas, X Lu, P Rao, ... Journal of Clinical Oncology 38 (6_suppl), 4-4, 2020 | 7 | 2020 |
| Targeting the molecular and immunologic features of leiomyosarcoma BM Cope, RS Traweek, R Lazcano, EZ Keung, AJ Lazar, CL Roland, ... Cancers 15 (7), 2099, 2023 | 6 | 2023 |
